Eagle Pharmaceuticals Inc (EGRX) — Cash Flow Quality Index
Eagle Pharmaceuticals Inc (EGRX) has a Cash Flow Quality Index of -0.02x as of June 2023. Operating cash flow of $-126.00K is below net income of $5.16 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore EGRX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Eagle Pharmaceuticals Inc Cash Flow Quality Index (2015–2020)
Historical Cash Flow Quality Index for Eagle Pharmaceuticals Inc across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Eagle Pharmaceuticals Inc operating cash flow efficiency.
Annual Cash Flow Quality Index for Eagle Pharmaceuticals Inc (2015–2020)
Year-by-year earnings quality comparison for Eagle Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 4.13x | $49.50 Million | $11.99 Million | ▲ +5.5% |
| 2019 | 3.91x | $55.99 Million | $14.31 Million | ▲ +138.2% |
| 2018 | 1.64x | $52.38 Million | $31.90 Million | ▲ +44.8% |
| 2017 | 1.13x | $58.92 Million | $51.94 Million | ▲ +73.6% |
| 2016 | 0.65x | $53.21 Million | $81.45 Million | ▲ +117.3% |
| 2015 | -3.78x | $-9.72 Million | $2.57 Million | — |